A team led by Vanderbilt University investigators has discovered two new genes — both coding for the signaling protein calmodulin — associated with severe early-onset disorders of heart rhythm.
An unexpected group of cells generates the coronary arteries and may be useful for regeneration therapies following injury to the heart.
Blocking a serotonin receptor may provide a novel therapy for heart valve disease.
Females may be at higher risk of potentially fatal heart condition due to gender differences in a protein involved in the heart’s electrical activity.
Enhancing stem cell survival is key to improving cell-based therapies for regenerative medicine, and a new drug could help.
Accessibility Tools